TRICOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tricor, and when can generic versions of Tricor launch?
Tricor is a drug marketed by Abbvie and is included in three NDAs.
The generic ingredient in TRICOR is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tricor
A generic version of TRICOR was approved as fenofibrate by RHODES PHARMS on May 13th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRICOR?
- What are the global sales for TRICOR?
- What is Average Wholesale Price for TRICOR?
Summary for TRICOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 138 |
Clinical Trials: | 21 |
Patent Applications: | 3,878 |
Drug Prices: | Drug price information for TRICOR |
Drug Sales Revenues: | Drug sales revenues for TRICOR |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TRICOR |
What excipients (inactive ingredients) are in TRICOR? | TRICOR excipients list |
DailyMed Link: | TRICOR at DailyMed |
Paragraph IV (Patent) Challenges for TRICOR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TRICOR | Tablets | fenofibrate | 48 mg | 021656 | 1 | 2008-07-01 |
TRICOR | Tablets | fenofibrate | 145 mg | 021656 | 1 | 2007-10-19 |
US Patents and Regulatory Information for TRICOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie | TRICOR (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 019304-004 | Jun 30, 1999 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021203-003 | Sep 4, 2001 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRICOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021203-003 | Sep 4, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-002 | Nov 5, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRICOR
See the table below for patents covering TRICOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 952829 | ⤷ Sign Up | |
European Patent Office | 1490030 | COMPOSITIONS NANOPARTICULAIRES D'INHIBITEURS D'ANGIOGENESE (NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS) | ⤷ Sign Up |
Canada | 2428785 | COMPOSITIONS NANOPARTICULAIRES COMPRENANT UN MEDICAMENT ET DES COPOLYMERES DE PYRROLIDONE DE VINYLE ET D'ACETATE DE VINYLE COMME STABILISANTS DE SURFACE (NANOPARTICULATE COMPOSITIONS COMPRISING A DRUG AND COPOLYMERS OF VINYL PYRROLIDONE AND VINYL ACETATE AS SURFACE STABILIZERS) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |